May 8, 2025
Finance

IIFL Finance Q4 profit falls YoY, but witnesses sequential rebound


IIFL Finance reported a consolidated net profit of ₹38.4 crore for the fourth quarter ended March 31, 2025, down sharply by 76.7% from ₹165 crore in the same period last year, as per the company’s standalone financial results. The year-on-year decline comes against the backdrop of regulatory challenges earlier in the financial year, including a temporary embargo on its gold loan business.

Net interest income (NII), a key indicator of lending profitability, also fell by 40% to ₹546.6 crore in Q4FY25 from ₹913 crore in Q4FY24. The drop in NII was attributed to lower income from off-book assets and a reduction in other income streams. Total income for the quarter declined by 36% year-on-year to ₹546.5 crore, despite sequential recovery.

However, the quarter showed signs of recovery on a quarter-on-quarter basis. Profit after tax surged 141% compared to the previous quarter’s ₹16 crore, aided by a 28% rise in assets under management (AUM) and a 325% jump in pre-provision operating profit. The company’s gold loan business rebounded with a 40% sequential growth in gold loan AUM, reaching ₹21,022 crore.

For the full financial year FY25, IIFL Finance reported a net loss of ₹409.6 crore compared to a profit of ₹584.8 crore in FY24. The loss was largely driven by the one-time exceptional provisions and disruption in key business segments during the first half of the year. The company maintains a capital adequacy ratio (CRAR) of 18.5% on a standalone basis and a liquidity buffer of ₹5,216 crore across the group.

Also Read: HCC Q4 Results | Net profit slumps 63% to ₹90 crore, revenue slides 23%



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent. View more
Accept
Decline